Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2022)
Lexaria Bioscience (LEXX) posted Other Operating Expenses of $1.5 million for Q3 2022, little changed sequentially from $1.5 million in Q1 2021.
Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2022) Analysis & Trends
Lexaria Bioscience has reported Other Operating Expenses for 6 years, with the latest figure at $1.5 million in Q3 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to $1.5 million in Q3 2022, while the trailing twelve-month figure through May 2023 was $1.5 million (changed N/A YoY) and the FY2022 annual result came in at $1.5 million, changed 0.0% from the prior year.
- Other Operating Expenses held at $1.5 million in Q3 2022 per LEXX's latest filing, from $1.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.5 million in Q1 2021 and troughed at -$852261.0 in Q4 2020.
- A 5-year average of $614977.5 and a median of $882705.0 in 2019 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2019 and 2020: Other Operating Expenses soared 27244.15% in 2019, then slumped 196.55% in 2020.
- Over 5 years, Other Operating Expenses stood at $551567.0 in 2018, then jumped by 60.04% to $882705.0 in 2019, then tumbled by 196.55% to -$852261.0 in 2020, then jumped by 278.67% to $1.5 million in 2021, then changed by 0.0% to $1.5 million in 2022.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $1.5 million, $1.5 million, and -$852261.0 for Q3 2022, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2022 | 1.52 Mn |
| Feb 28, 2021 | 1.52 Mn |
| Nov 30, 2020 | -852,261.00 |
| Aug 31, 2020 | 18,198.00 |
| May 31, 2020 | -18,198.00 |
| Nov 30, 2019 | 882,705.00 |
| Aug 31, 2019 | 1.11 Mn |
| May 31, 2019 | 931,860.00 |
| Feb 28, 2019 | 1.09 Mn |
| Nov 30, 2018 | 551,567.00 |
| Feb 28, 2018 | 3,998.00 |
| Nov 30, 2017 | 440,701.00 |
| Aug 31, 2017 | 727,596.00 |
| May 31, 2017 | 364,156.00 |